Our findings revealed significant upregulation of TRIM37 expression in sunitinib-resistant tissue, and elevated TRIM37 expression in both RCC tumors and cells, the high level of TRIM37 was associated with advanced TNM stage, distant metastasis and poor prognosis. Here, TRIM37 is linked to renal cell carcinoma.